You are viewing an incomplete version of our website. Please click to reload the website as full version.

S100 Calcium Binding Protein B (S100B) (Center) Peptide

Details for Product No. ABIN692912, Supplier: Log in to see
Protein Name
  • AI266795
  • S100
  • S100a
  • NEF
  • S100-B
  • S100beta
  • S100P
  • AI850290
  • Bpb
Protein Region
Center
Source
Synthetic
Peptide Type
Synthetic
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Background The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21, however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes.
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Sahoo, Tröger, Heinemann et al.: "Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B." in: FEBS letters, Vol. 584, Issue 18, pp. 3896-900, 2010 (PubMed).

Egberts, Momkvist, Egberts et al.: "Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients." in: Anticancer research, Vol. 30, Issue 5, pp. 1799-805, 2010 (PubMed).

van Dieck, Lum, Teufel et al.: "S100 proteins interact with the N-terminal domain of MDM2." in: FEBS letters, Vol. 584, Issue 15, pp. 3269-74, 2010 (PubMed).

Lin, Yang, Wilder et al.: "The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma." in: The Journal of biological chemistry, Vol. 285, Issue 35, pp. 27487-98, 2010 (PubMed).